PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank78
3Y CAGR+15.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+15.7%/yr
Quarterly compound
Percentile
P78
Within normal range
vs 3Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.27% |
| Q3 2025 | -8.29% |
| Q2 2025 | -0.20% |
| Q1 2025 | -9.63% |
| Q4 2024 | 1.06% |
| Q3 2024 | -953.75% |
| Q2 2024 | 90.13% |
| Q1 2024 | -33.92% |
| Q4 2023 | 22.82% |
| Q3 2023 | -21.38% |
| Q2 2023 | 14.06% |
| Q1 2023 | 2.04% |
| Q4 2022 | 8.56% |
| Q3 2022 | -22.52% |
| Q2 2022 | 24.00% |
| Q1 2022 | -49.63% |
| Q4 2021 | 2.98% |
| Q3 2021 | -34.16% |
| Q2 2021 | 28.39% |
| Q1 2021 | -25.14% |
| Q4 2020 | -39.48% |
| Q3 2020 | -7.21% |
| Q2 2020 | 15.26% |
| Q1 2020 | -58.73% |
| Q4 2019 | 10.48% |
| Q3 2019 | -2.17% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |